These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 34155880)
1. Long non-coding RNA OIP5-AS1 serves as a competing endogenous RNA to modulate X-linked inhibitor of apoptosis protein expression via adsorbing miR-429 in papillary thyroid cancer. Yu CS; Wang YB; Li Q; Yang EL; Dong BB J Biol Regul Homeost Agents; 2021; 35(3):909-920. PubMed ID: 34155880 [TBL] [Abstract][Full Text] [Related]
2. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer. Zhang X; Li D; Jia C; Cai H; Lv Z; Wu B Cell Death Dis; 2021 Jun; 12(6):617. PubMed ID: 34131102 [TBL] [Abstract][Full Text] [Related]
3. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p. Wang D; Zheng Y Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis. Zhuang X; Tong H; Ding Y; Wu L; Cai J; Si Y; Zhang H; Shen M Cell Death Dis; 2019 Aug; 10(8):620. PubMed ID: 31409775 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis. Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis. Yi D; Zhang D; He J Cell Cycle; 2021 Dec; 20(24):2619-2637. PubMed ID: 34781815 [TBL] [Abstract][Full Text] [Related]
7. LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis. Zhang X; Zhang X; Jia Q; Li H; Ma R; Yang G; Yin F; Jiang N; Yin D BMC Cancer; 2022 Mar; 22(1):344. PubMed ID: 35351042 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma. Feng Z; Chen R; Huang N; Luo C Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor. Feng K; Liu Y; Xu LJ; Zhao LF; Jia CW; Xu MY Biomed Pharmacother; 2018 Aug; 104():686-698. PubMed ID: 29803929 [TBL] [Abstract][Full Text] [Related]
10. NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma. Yang C; Liu Z; Chang X; Xu W; Gong J; Chai F; Cui D J Cell Biochem; 2020 Feb; 121(2):2009-2018. PubMed ID: 31692033 [TBL] [Abstract][Full Text] [Related]
11. LncRNA Nian R; Li W; Li X; Zhang J; Li W; Pan F; Cheng J; Jin X Arch Endocrinol Metab; 2023 Jan; 67(1):55-63. PubMed ID: 35929906 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410. Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093 [TBL] [Abstract][Full Text] [Related]
13. RNF185 antisense RNA 1 (RNF185-AS1) promotes proliferation, migration, and invasion in papillary thyroid carcinoma. Liu D; Zhang M; Song Y; Yang N Anticancer Drugs; 2022 Jul; 33(6):595-606. PubMed ID: 35324519 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA opa-interacting protein 5 antisense transcript 1 promotes proliferation and invasion through elevating integrin α6 expression by sponging miR-143-3p in cervical cancer. Yang J; Jiang B; Hai J; Duan S; Dong X; Chen C J Cell Biochem; 2019 Jan; 120(1):907-916. PubMed ID: 30188591 [TBL] [Abstract][Full Text] [Related]
15. lncRNA RPL34-AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR-3663-3p/RGS4 in papillary thyroid cancer. Ji L; Fan X; Zhou F; Gu J; Deng X J Cell Physiol; 2020 Apr; 235(4):3669-3678. PubMed ID: 31587286 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA AGAP2-AS1 promotes proliferation and metastasis in papillary thyroid cancer by miR-628-5p/KLF12 axis. Xu C; Shao Y; Liu J; Yao X; Quan F; Zhao Q; Zhao R; Kou B; Li H; Han P; Wang X; Bai Y; Zheng Z; Zhang S J Bioenerg Biomembr; 2021 Apr; 53(2):235-245. PubMed ID: 33604734 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis. Wu S; Zhu J; Jiang T; Cui T; Zuo Q; Zheng G; Li G; Zhou J; Chen X Clin Epigenetics; 2024 Jan; 16(1):10. PubMed ID: 38195623 [TBL] [Abstract][Full Text] [Related]
18. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway. Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA OPA-interacting protein 5 antisense transcript 1 upregulated SMAD3 expression to contribute to metastasis of cervical cancer by sponging miR-143-3p. Chen X; Xiong D; Yang H; Ye L; Mei S; Wu J; Chen S; Shang X; Wang K; Huang L J Cell Physiol; 2019 Apr; 234(4):5264-5275. PubMed ID: 30341904 [TBL] [Abstract][Full Text] [Related]
20. LncRNA Opa interacting protein 5-antisense RNA 1 (OIP5-AS1) promotes the migration, invasion and epithelial-mesenchymal transition (EMT) through targeting miR-147a/insulin-like growth factor 1 receptor (IGF1R) pathway in cervical cancer tissues and cell model. Zhang L; Cai Y; Tian C; Li Y; Ma K; Gao X; Liu L; Jiang Y; Wen W; Ma Z J Obstet Gynaecol Res; 2022 May; 48(5):1222-1232. PubMed ID: 35233882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]